schülke focuses on women's intimate health as a globally relevant topic and presents its innovative octenisept^® vaginal therapeutic agent

• It is estimated that 75% of women suffer from a vaginal infection at least once in their lives. Around 66% of them rely on self-medication and mistakenly opt for an antifungal medication, even though they suffer from a mixed or bacterial infection.¹
  
  
• Pharmacists and gynecologists are faced with the challenge of offering their patients innovative solutions for vaginal infections that are both effective and safe.
  
  
• With its innovative octenisept^® vaginal therapeutic, schülke offers a safe solution for the most common vaginal diseases caused by both bacterial and fungal infections.
  
  

Every woman can be affected by a vaginal infection several times in her life. However, many sufferers are reluctant to visit a doctor or prefer to take over-the-counter medication from the pharmacy to treat the symptoms. On the occasion of World Women's Health Day, schülke is drawing attention to the topic of women's intimate health and, with its octenisept^® vaginal therapeutic, is offering an over-the-counter solution that represents an improvement for women's intimate health. The product offers gynecologists and pharmacists an effective and safe treatment recommendation to meet the indication-specific needs of their patients for both fungal and bacterial infections.

Women's intimate health is highly relevant worldwide and deserves special attention. However, many women find it difficult to talk about complaints in the intimate area. They put off seeing a specialist or going to the pharmacy - until their quality of life and well-being suffer so much that there is no way around a medical consultation. It is estimated that around 75% of women suffer from a vaginal infection at least once in their lives.

A vaginal infection does not go away on its own

Pharmacists and gynecologists are faced with the challenge of offering their patients innovative solutions for vaginal infections that are both effective and safe. The therapy for this is usually indication-specific. In order to select the appropriate therapeutic agent, the pathogen can be determined in the gynecologist's office with a smear and microscopic examination. However, many women who are already aware of their symptoms prefer to treat them with over-the-counter medication from the pharmacy. More than half of all women (66%1) mistakenly opt for antifungal medication, even though they are suffering from a mixed or bacterial infection. This is where the octenisept^® vaginal therapeutic from schülke comes in, offering a targeted and effective treatment option for symptoms that is effective for both bacterial and fungal infections (candidiasis).

octenisept^® vaginal therapeutic from schülke addresses a broad spectrum of efficacy

schülke's vaginal therapeutic has been carefully developed to address the indication-specific needs of women while meeting high safety standards and a broad spectrum of efficacy. This is because fungal infections (candidiasis), bacterial vaginosis or mixed infections can cause similar symptoms, such as discharge, itching, redness and burning.

Pharmacists play a crucial role in ensuring optimal care for patients. The octenisept^® vaginal therapeutic from schülke offers them an innovative solution to provide an evidence-based treatment recommendation to those affected. It was developed as a spray including a vaginal applicator to ensure easy application and good compliance so that patients receive rapid relief. It is also suitable for treating partners and pregnant women from the fourth month of pregnancy. The octenisept^® vaginal therapeutic is available over the counter from pharmacies.

*Candidoses

¹Ferris, Daron G et al. "Over-the-counter antifungal drug misuse associated with patientdiagnosedvulvovaginal candidiasis." Obstetrics and gynecology vol. 99.3 (2002): 419-25